About
CERTIS Therapeutics is a healthcare technology company that specializes in minimally invasive therapy solutions using real-time MRI guidance. Founded as a spinoff from IHU Liryc in Bordeaux, France, the company focuses on enhancing the precision and safety of thermal ablation treatments, which are used to destroy abnormal cells, including cancer cells and those related to cardiac arrhythmias. The company develops both software and hardware products that provide high accuracy in delivering thermal energy during ablation procedures. Their software features fast image reconstruction and 3D real-time temperature mapping, allowing clinicians to closely monitor treatments. The hardware is designed for precise ablation in various organs, including the heart and liver. CERTIS Therapeutics supports multiple thermal ablation techniques, such as radiofrequency, microwave, laser, and focused ultrasound, making its solutions applicable in oncology, cardiology, and neurology. The company is headquartered in Pessac, Nouvelle-Aquitaine, France, and has a team of fewer than 25 employees.
Technologies
Keywords
Company Information
-
Employees 9
-
Founded 2019
Location
Avenue du Haut-Leveque, Pessac, Nouvelle-Aquitaine, France, 33600